Rate of Clinical Trial Failure in Head & Neck Cancer Has Grown Since 2000
THURSDAY, Jan. 15, 2026 -- The rate of early termination or withdrawal in head and neck squamous cell carcinoma (HNSCC) clinical trials (CTs) has increased since 2000, with strategic decisions and poor recruitment as the main reasons, according to a...
Read more »